Breakthrough treatments for Ebola virus disease, but no access-what went wrong, and how can we do better?
Lancet Infect Dis
; 23(7): e253-e258, 2023 Jul.
Article
in En
| MEDLINE
| ID: mdl-36682365
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hemorrhagic Fever, Ebola
/
Epidemics
Type of study:
Clinical_trials
Limits:
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
Lancet Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2023
Type:
Article